OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension
Gwenolé Loas, Philippe van de Borne, Gil Darquennes, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 380-380
Open Access | Times Cited: 11

Showing 11 citing articles:

Lipid-targeting antiviral strategies: current state and future perspectives
Ana-Belén Blázquez, Patricia Mingo‐Casas, Ernesto Quesada, et al.
Antiviral Research (2025), pp. 106103-106103
Closed Access

Antihypertensive Drug Use and COVID‐19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study
Merodean Huntsman, Jessica L. Marquez, Gregory J. Stoddard, et al.
Journal of Clinical Hypertension (2025) Vol. 27, Iss. 2
Open Access

Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Pyrimidine Derivatives as Potential Calcium Channel Blockers
Yasser M. Zohny, Samir M. Awad, Maha Abubakr Feissal Rabie, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4869-4869
Open Access | Times Cited: 8

A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice
Jide Tian, Barbara J. Dillion, Jill Henley, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12

Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
Nicolas Hoertel, Katayoun Rezaei, Marina Sánchez‐Rico, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 7

Acid sphingomyelinase (ASM) and COVID‐19: A review of the potential use of ASM inhibitors against SARS‐CoV‐2
Pedro José Tronco Pauletto, Cássia P. Delgado, João Batista Teixeira da Rocha
Cell Biochemistry and Function (2023) Vol. 41, Iss. 3, pp. 284-295
Closed Access | Times Cited: 5

Changes in arterial pH do not explain the reductions in ionised calcium observed during COVID-19 infection
John Scott Frazer, Robin Lucas-Evans, Asghar Dayala, et al.
Advances in Medical Sciences (2024) Vol. 69, Iss. 1, pp. 51-55
Closed Access

A Real-World Study on the Short-Term Efficacy of Amlodipine in Treating Hypertension Among Inpatients
Tingting Wang, Juntao Tan, Tiantian Wang, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 121-137
Open Access

Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study
Kun Zhang, Hengxing Gao, Mingwei Chen
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1

Antihypertensive Drugs Therapy in Hypertension and Covid-19 Comorbidity
Emuesiri Goodies Moke, Endurance Efe Ahama, Pere-Ebi Yabrade Toloyai, et al.
Biology Medicine & Natural Product Chemistry (2023) Vol. 12, Iss. 1, pp. 191-196
Open Access

GABA-receptors are a new druggable target for limiting disease severity, lung viral load, and death in SARS-CoV-2 infected mice
Jide Tian, Barbara J. Dillion, Jill Henley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access

Page 1

Scroll to top